Brunner Discusses Dosing Approaches for ESA and Novel Therapies for Low-Risk MDS
During a Case-Based Roundtable® event, Andrew M. Brunner, MD, discussed dosing strategy for erythropoiesis-stimulating agents as well as dose modifications and safety for the novel agents imetelstat and luspatercept.
https://www.targetedonc.com/view/brunner-discusses-dosing-approaches-for-esa-and-novel-therapies-for-low-risk-mds
#doping #cleansport #antidoping #datajournalism